Peroxiredoxin III Protects Tumor Suppressor PTEN from Oxidation by 15-Hydroperoxy-eicosatetraenoic Acid

Oxid Med Cell Longev. 2019 Sep 15:2019:2828493. doi: 10.1155/2019/2828493. eCollection 2019.

Abstract

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a lipid and protein phosphatase that coordinates various cellular processes. Its activity is regulated by the reversible oxidation of an active-site cysteine residue by H2O2 and thioredoxin. However, the potential role of lipid peroxides in the redox regulation of PTEN remains obscure. To evaluate this, 15-hydroperoxy-eicosatetraenoic acid (15s-HpETE), a lipid peroxide, was employed to investigate its effect on PTEN using molecular and cellular-based assays. Exposure to 15s-HpETE resulted in the oxidation of recombinant PTEN. Reversible oxidation of PTEN was also observed in mouse embryonic fibroblast (MEF) cells treated with a 15s-HpETE and Lipofectamine mixture. The oxidative dimerization of thioredoxin was found simultaneously. In addition, the absence of peroxiredoxin III aggravated 15s-HpETE-induced PTEN oxidation in MEF cells. Our study provides novel insight into the mechanism linking lipid peroxidation to the etiology of tumorigenesis.

MeSH terms

  • Animals
  • Humans
  • Leukotrienes / pharmacology
  • Leukotrienes / therapeutic use*
  • Lipid Peroxides / pharmacology
  • Lipid Peroxides / therapeutic use*
  • Mice
  • Oxidation-Reduction
  • PTEN Phosphohydrolase / drug effects*
  • Peroxiredoxin III / pharmacology
  • Peroxiredoxin III / therapeutic use*
  • Transfection

Substances

  • Leukotrienes
  • Lipid Peroxides
  • 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid
  • Peroxiredoxin III
  • PTEN Phosphohydrolase
  • PTEN protein, human